Skip to content

Investigation of the Duration of Low-intensity Focused Ultrasound

Investigation of the Duration of Low-intensity Focused Ultrasound

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05147103
Enrollment
80
Registered
2021-12-07
Start date
2022-08-26
Completion date
2026-06-30
Last updated
2025-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Development of LIFU for Clinical Purposes

Keywords

low-intensity focused ultrasound, transcranial magnetic stimulation

Brief summary

This project examines the effects of various durations of noninvasive neuromodulation on muscle contractions. The investigators believe this study will help to better understand noninvasive brain stimulation techniques that may have the potential to aid in addiction, pain, and mental health issues. Participants undergo structural imaging, a functional Magnetic Resonance Image (fMRI) and computed tomography (CT). These images are used to align the low-intensity focused ultrasound (LIFU) and transcranial magnetic stimulation (TMS) devices to temporarily change brain activity. Electromyography (EMG) will be used to record muscle contractions of the hand.

Interventions

LIFU application using various durations, responses of neuromodulation recorded using TMS and EMG.

Sponsors

Virginia Polytechnic Institute and State University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Multi-visit study, testing various LIFU durations

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Above criteria and must understand and speak English.

Exclusion criteria

* Contraindications to MRI, CT, or TMS 1. Claustrophobia 2. Pacemaker, aneurysm clips, neurostimulators, cochlear implants, metal in eyes, steel worker, or other implants. 3. Pregnancy 4. Active medical disorder or treatment with potential CNS effects 5. History of neurologic disorder 6. History of head injury resulting in loss of consciousness for \>10 minutes 7. History of alcohol or drug dependence

Design outcomes

Primary

MeasureTime frameDescription
WaveformsOutcomes assessed throughout participation - an average of 3 weeks.Changes in waveform peak will be observed per each variable application of LIFU

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026